Related Experiment Video

Updated: May 31, 2026

Quantification of γH2AX Foci in Response to Ionising Radiation
06:53

Quantification of γH2AX Foci in Response to Ionising Radiation

Published on: April 6, 2010

Retention of γH2AX foci as an indication of lethal DNA damage

Peggy L Olive1

  • 1British Columbia Cancer Agency, BC, Canada. polive@bccrc.ca

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|June 28, 2011
PubMed

Insights

Residual gamma-H2AX foci can indicate early tumor resistance to radiotherapy. This biomarker may help identify treatment-resistant cells, guiding clinical decisions and improving patient outcomes in cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Radiotherapy Research

Background:

  • Predicting clinical response to cancer treatment using biological markers is crucial for improving patient outcomes.
  • Tumor cell death often results from unrepaired complex DNA damage.
  • Gamma-H2AX foci are established markers for DNA double-strand breaks.

Purpose of the Study:

  • To review the evidence supporting the use of residual gamma-H2AX foci as an early indicator of tumor response to radiotherapy.
  • To explore the potential of gamma-H2AX foci in identifying treatment-resistant tumor cells.
  • To assess the utility of gamma-H2AX foci in guiding radiotherapy and chemotherapy decisions.

Main Methods:

  • Review of existing scientific literature and studies on DNA damage response and cancer treatment.
  • Analysis of the role of gamma-H2AX foci in marking unrepaired DNA double-strand breaks.
  • Evaluation of data correlating residual gamma-H2AX foci with treatment resistance in preclinical and clinical settings.

Main Results:

  • Residual gamma-H2AX foci can serve as a biomarker for unrepaired DNA damage in tumors post-treatment.
  • Evidence suggests a correlation between the presence of residual gamma-H2AX foci and resistance to radiotherapy.
  • The predictive value of gamma-H2AX foci may be applicable in radiotherapy, alone or combined with chemotherapy.

Conclusions:

  • Residual gamma-H2AX foci show promise as an early indicator of tumor response to radiotherapy.
  • This biomarker has the potential to identify treatment-resistant cells, informing therapeutic strategies.
  • Further research is warranted to establish the limitations and optimize the clinical application of gamma-H2AX foci in cancer treatment.

More Related Videos

Quantitation of γH2AX Foci in Tissue Samples08:48

Quantitation of γH2AX Foci in Tissue Samples

Published on: June 28, 2010

Evaluation of the Spatial Distribution of γH2AX following Ionizing Radiation09:28

Evaluation of the Spatial Distribution of γH2AX following Ionizing Radiation

Published on: August 7, 2010

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Fixing Double-strand Breaks02:04

Fixing Double-strand Breaks

The double-stranded structure of DNA has two major advantages. First, it serves as a safe repository of genetic information where one strand serves as the back-up in case the other strand is damaged. Second, the double-helical structure can be wrapped around proteins called histones to form nucleosomes, which can then be tightly wound to form chromosomes. This way, DNA chains up to 2 inches long can be contained within microscopic structures in a cell. A double-stranded break not only damages...
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...